全文获取类型
收费全文 | 365829篇 |
免费 | 29692篇 |
国内免费 | 12396篇 |
专业分类
耳鼻咽喉 | 3724篇 |
儿科学 | 6708篇 |
妇产科学 | 5157篇 |
基础医学 | 60702篇 |
口腔科学 | 9246篇 |
临床医学 | 26799篇 |
内科学 | 49299篇 |
皮肤病学 | 7300篇 |
神经病学 | 23195篇 |
特种医学 | 10267篇 |
外国民族医学 | 131篇 |
外科学 | 30199篇 |
综合类 | 52513篇 |
现状与发展 | 69篇 |
一般理论 | 8篇 |
预防医学 | 19692篇 |
眼科学 | 5988篇 |
药学 | 38865篇 |
83篇 | |
中国医学 | 17773篇 |
肿瘤学 | 40199篇 |
出版年
2024年 | 619篇 |
2023年 | 4558篇 |
2022年 | 8659篇 |
2021年 | 13582篇 |
2020年 | 11514篇 |
2019年 | 11439篇 |
2018年 | 11681篇 |
2017年 | 12565篇 |
2016年 | 12857篇 |
2015年 | 13532篇 |
2014年 | 17714篇 |
2013年 | 23023篇 |
2012年 | 19215篇 |
2011年 | 22703篇 |
2010年 | 16834篇 |
2009年 | 16904篇 |
2008年 | 18628篇 |
2007年 | 19778篇 |
2006年 | 18510篇 |
2005年 | 16894篇 |
2004年 | 14726篇 |
2003年 | 13101篇 |
2002年 | 10624篇 |
2001年 | 9227篇 |
2000年 | 7740篇 |
1999年 | 6806篇 |
1998年 | 5867篇 |
1997年 | 5643篇 |
1996年 | 5117篇 |
1995年 | 4557篇 |
1994年 | 4090篇 |
1993年 | 3416篇 |
1992年 | 2935篇 |
1991年 | 2725篇 |
1990年 | 2214篇 |
1989年 | 1898篇 |
1988年 | 1796篇 |
1987年 | 1540篇 |
1986年 | 1430篇 |
1985年 | 1971篇 |
1984年 | 1658篇 |
1983年 | 1223篇 |
1982年 | 1250篇 |
1981年 | 1047篇 |
1980年 | 954篇 |
1979年 | 751篇 |
1978年 | 503篇 |
1977年 | 406篇 |
1976年 | 364篇 |
1975年 | 228篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
201.
202.
《Molecular therapy》2020,28(6):1432-1441
- Download : Download high-res image (155KB)
- Download : Download full-size image
203.
《Biomaterials》2015
Mesoporous silica nanoparticles (MSNs) can provide a structural foundation for a new generation of nanocarriers with a broad range of functionalities. Multifunctional MSNs can serve as all-in-one diagnostic and therapeutic tools that can be used to simultaneously visualize and treat various diseases, such as cancer. This research study is the first time that two lanthanide-based imaging systems have been combined to incorporate controlled drug release and targeted tracing into a single MSN-based nano-platform for a novel theranostic drug delivery system. Doping lanthanide ions, i.e., europium (Eu) and gadolinium (Gd) ions, into an MSN structure (EuGd-MSNs) imparts fluorescence and magnetism to the nanostructure that can be used to develop magnetic resonance imaging (MRI) and biological fluorescence tools. Current cancer research has revealed that most human cancer cells express a large number of folate receptors on their surface. Grafting folic acid (FA) onto the EuGd-MSN surface (EuGd-FA-MSNs) imparts a targeting function to the MSN because of the specificity of the binding of FA to cell surface receptors. Furthermore, grafting anticancer drugs, such as camptothecin (CPT), onto the surface of these MSNs by forming disulfide bonds (EuGd-SS-CPT-FA-MSNs) enables intracellular controlled drug release. A high concentration of intracellular glutathione cleaves the disulfide bond to release the drug and treat the disease. The results of in vitro and in vivo studies show that the functionalized MSNs can be successfully used as a platform to integrate dual-imaging, targeting, and therapeutic treatment in multifunctional diagnosis drug delivery systems. 相似文献
204.
《Biomaterials》2015
Significant efforts have been invested into the differentiation of stem cells into functional hepatocyte-like cells that can be used for cell therapy, disease modeling and drug screening. Most of these efforts have been concentrated on the use of growth factors to recapitulate developmental signals under in vitro conditions. Using small molecules instead of growth factors would provide an attractive alternative since small molecules are cell-permeable and cheaper than growth factors. We have developed a protocol for the differentiation of human embryonic stem cells into hepatocyte-like cells using a predominantly small molecule–based approach (SM-Hep). This 3 step differentiation strategy involves the use of optimized concentrations of LY294002 and bromo-indirubin-3’-oxime (BIO) for the generation of definitive endoderm; sodium butyrate and dimethyl sulfoxide (DMSO) for the generation of hepatoblasts and SB431542 for differentiation into hepatocyte-like cells. Activin A is the only growth factor required in this protocol. Our results showed that SM-Hep were morphologically and functionally similar or better compared to the hepatocytes derived from the growth-factor induced differentiation (GF-Hep) in terms of expression of hepatic markers, urea and albumin production and cytochrome P450 (CYP1A2 and CYP3A4) activities. Cell viability assays following treatment with paradigm hepatotoxicants Acetaminophen, Chlorpromazine, Diclofenac, Digoxin, Quinidine and Troglitazone showed that their sensitivity to these drugs was similar to human primary hepatocytes (PHHs). Using SM-Hep would result in 67% and 81% cost reduction compared to GF-Hep and PHHs respectively. Therefore, SM-Hep can serve as a robust and cost effective replacement for PHHs for drug screening and development. 相似文献
205.
206.
207.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217
208.
Bimal Bhindi Christine M. Lohse Phillip J. Schulte Ross J. Mason John C. Cheville Stephen A. Boorjian Bradley C. Leibovich R. Houston Thompson 《European urology》2019,75(5):766-772
Background
Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit.Objective
To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30 d following PN and RN, separately.Design, setting, and participants
In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15 ml/min/1.73 m2.Intervention
RN and PN.Outcome measurements and statistical analysis
Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal , which ranges from 0 to 1, with higher values indicating increased predictive ability.Results and limitations
The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66 ml/min/1.73 m2 (standard deviation [SD] = 18) and 72 ml/min/1.73 m2 (SD = 20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal ). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal ). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts.Conclusions
We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making.Patient summary
We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors. 相似文献209.
210.